|
BIO-TECH SYSTEMS INC. announces the publication of: BIO-TECH Report #340, The Market for PET Radiopharmaceuticals & PET Imaging
The PET Report Includes:
- Present and Emerging Markets for PET Imaging
- New Markets for PET Radiopharmaceuticals
- Good Opportunities for PET Cardiology Products
- New PET Agents for Alzheimer's on the Threshold
- New Products and Novel Biomarkers for Oncology
- U.S and Worldwide Markets for PET Scanners
- New Technology Platform with Introduction of PET-MR
- Market Assessment and Sales Forecasts to 2018
GROWTH OF PET PROCEDURES AND RADIOPHARMACEUTICAL SALES
PET procedures increased 9% in 2010 to 2.1 million, with growth continuing in 2011. Physicians had more confidence in PET’s capabilities in diagnosis, staging and management of disease. They were also better adjusted to the reimbursement requirements of Medicare and insurance carriers. This allowed PET to be used more effectively with average procedure volume increasing and scanner utilization improving. The less efficient providers continued to sell their practices to hospitals, consolidating the installed base and improving the economics of PET. Sales of FDG increased about 9% to about $300 million and prices were relatively stable. Growth should continue and will accelerate over the next several years as new products are introduced. Therefore, FDG sales of $300 million in 2010 will increase to $825 million by 2018, while total PET radiopharmaceuticals sales will grow to $4.1 billion by 2018. Of this total, $3.1 billion will be from sales of new products across a wide spectrum of applications in cardiology, neurology and oncology. As new products enter the mainstream, it will stimulate growth of procedure volume and encourage more users to pursue sophisticated imaging applications. This will improve PET’s prospects and help accelerate future growth.
SALES GROWTH OF PET IMAGING SYSTEMS
In 2010, U.S. sales of PET scanners increased 24% over 2009. Previous uncertainties were replaced with more confidence in the future of PET and its role in diagnosis and management of disease. The successful introduction of PET-MR with its high price was a good example. Manufacturers took orders for 179 PET systems in the U.S. and 274 systems internationally. Uncertainties over reimbursement and excess capacity seemed less of an issue in 2010 than previously. In addition, there was more choice for users with available systems to fit all budgets. Scanner manufacturers have all introduced advanced time-of-flight PET systems with 64-slice CT's while expanding their product lines to include functional scanners affordably priced. The market has responded well to the added choice, which should help future sales. International orders for PET systems have exceeded the U.S. recently in both unit orders and sales volume with greater emphasis on high end systems. Based on these observations, both U.S. and international sales will grow at 12-15% per year over the next several years with international sales comprising about 65% of the total. Therefore, worldwide sales of PET scanners will increase from $791 million in 2010 to $1,741 million by 2018.
Please follow one of the links below, or on the left, to find out more information
about BIO-TECH Report #340. If you are interested in purchasing BIO-TECH Report #340, please follow this link to our Online
Order Form.
To download a detailed Table of Contents (TOC) for BIO-TECH Report #340, please click on one of the two links below. The documents are a Microsoft Word 97-2000 file and an Adobe Acrobat 6 PDF file.
Download TOC in MS Word format (40KB)
Download TOC in Adobe PDF format (25KB)
|